Patents by Inventor Florian VOGL

Florian VOGL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane
    Patent number: 11872282
    Abstract: Methods and compositions for treating ovarian cancer in a human patient with ascites by administering a therapeutically effective amount of an Ang2 inhibitor in combination with a taxane.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: January 16, 2024
    Assignee: Amgen Inc.
    Inventors: Bruce Allen Bach, Florian Vogl
  • New Use of Inhibitors of the Notch Signalling Pathway
    Publication number: 20230338347
    Abstract: The present invention relates to new uses and dosage regimens of inhibitors of the Notch signalling pathway such as 6-(4-Tert-Butylphenoxy)Pyridin-3-Amine for the treatment of tumours.
    Type: Application
    Filed: September 16, 2021
    Publication date: October 26, 2023
    Inventors: Michael Bauer, Rajwinder Lehal, Maximilien Murone, Pavel Pisa, Florian Vogl, Maria Bobadilla
  • TREATMENT OF OVARIAN CANCER IN PATIENTS WITH ASCITES USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE
    Publication number: 20210060161
    Abstract: Methods and compositions for treating ovarian cancer in a human patient with ascites by administering a therapeutically effective amount of an Ang2 inhibitor in combination with a taxane.
    Type: Application
    Filed: November 3, 2020
    Publication date: March 4, 2021
    Applicant: Amgen Inc.
    Inventors: Bruce Allen BACH, Florian VOGL
  • Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane
    Patent number: 10857229
    Abstract: Methods and compositions for treating ovarian cancer in a human patient with ascites by administering a therapeutically effective amount of an Ang2 inhibitor in combination with a taxane.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: December 8, 2020
    Assignee: Amgen Inc.
    Inventors: Bruce Allen Bach, Florian Vogl
  • SYSTEM AND METHOD FOR NONINVASIVE EVALUATION OF PROSTHESIS LOOSENING, AND/OR FRACTURE HEALING
    Publication number: 20190336071
    Abstract: Disclosed embodiments concern a system for monitoring one or more mechanical properties of an assembly of rigid bodies, comprising: at least one first transducer that is operative to excite mechanical waves that propagate from a first rigid body of the assembly via a contact interface to a second rigid body of the assembly; at least one distant sensor that is operative to sense one or more physical stimuli relating to the mechanical waves propagating in the second rigid body; a memory; and a processor that is operative to execute instructions stored in the memory to perform the following steps: receiving electronic signals that relate to the mechanical waves propagating in the first and second rigid body; and determining, based on the received electronic signals, a state and/or a change in a state of a structural feature of the assembly.
    Type: Application
    Filed: December 5, 2017
    Publication date: November 7, 2019
    Inventors: William TAYLOR, Florian VOGL
  • TREATMENT OF OVARIAN CANCER IN PATIENTS WITH ASCITES USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE
    Publication number: 20180169231
    Abstract: Methods and compositions for treating ovarian cancer in a human patient with ascites by administering a therapeutically effective amount of an Ang2 inhibitor in combination with a taxane.
    Type: Application
    Filed: April 28, 2016
    Publication date: June 21, 2018
    Applicant: AMGEN INC.
    Inventors: Bruce Allen BACH, Florian VOGL